Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
It had been reported that four domain names which appeared to support Clive Lewis for Labour leader were registered in June last year.
The EU flag symbolises unity between European countries.
Shadow business secretary Rebecca Long-Bailey has called for "immediate" relief to prevent thousands of companies going out of business.